InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Monday, 04/07/2014 11:50:34 AM

Monday, April 07, 2014 11:50:34 AM

Post# of 346460
Entdoc I have a question. Since this is true in deep lung cancer...

"Peregrine's lead immunotherapeutic antibody candidate bavituximab administered with stereotactic body radiation therapy (SBRT) showed a 100% improvement in survival and favorable tumor eradication in a model of non-small cell lung cancer (NSCLC) compared to irradiation alone."

...is it likely that the Bavi/sterotactic body radiation combination could also be also be effective against many other deep inoperable cancers?



If this is the case....isn't this HUGE NEWS?

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News